No phaseCompleted

Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product

Evaluation of the Anti-aging Efficacy of a Novel Cosmetic Product

Sponsor
Amazentis SA (Industry)
Enrolment
48 enrolled
Conditions
Skin Aging
Interventions
Topical Placebo Cream; Topical Cream with 0.5% Active; Topical Cream with 1% Active
Ages
adults, older adults
Registry
NCT05300984

From the registry

The aim of this study is to investigate the effect of cosmetic products with two different concentrations of the active on skin aging and in acting on the mitochondrial health of skin in comparison to a placebo product.

Primary outcomes

  • Change from baseline in skin mitochondrial health and biological age (assessed on skin biopsies) after 8 weeks
  • Change from baseline in skin barrier function (assessed on transepidermal waterloss by Tewameter [g/(m²h)]) after 8-weeks
Full record on ClinicalTrials.gov